Niki BioSolutions, Inc. (NIKI) EBT Margin (2024 - 2025)
Niki BioSolutions' (NIKI) quarterly EBT Margin came in at 207.58% in Q4 2025, down 16424.0% YoY from N/an in Q4 2024, and up 34.37% on a QoQ basis from 316.28% in Q3 2025.
Niki BioSolutions, Inc. (NIKI) EBT Margin (2024 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 2 years of EBT Margin data on file, last reported at 207.58% in Q4 2025.
- Quarterly EBT Margin fell 16424.0% year-over-year to 207.58% in Q4 2025, while the trailing twelve-month figure through Nov 2025 was 60.24% (changed N/A YoY) and the FY2025 annual result came in at 114.81%, down 7692.0% from the prior year.
- EBT Margin advanced to 207.58% in Q4 2025, from 316.28% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 43.33% in Q4 2024 to a low of 316.28% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -207.58% |
| Aug 31, 2025 | -316.28% |
| Nov 30, 2024 | -43.33% |
| Aug 31, 2024 | -81.52% |